logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

WCLC 2018 — EGFR+ NSCLC: gefitinib+platinum-doublet chemotherapy improves OS

Japanese study shows better OS, PFS vs gefinitib alone.